Beyond the vaccine race
The firm he kickstarted a decade ago is racing to immunise the world against Covid-19. Now, Robert Langer, co-founder of Moderna, is shaping the next generation of innovative medical solutions.
FOR scientist-entrepreneur Robert Langer, the miniscule genetic material mRNA belies an immense lesson for innovators: Where there is "great science", keep persisting.
The 72-year-old has found this to be true as a co-founder of Moderna . The Massachusetts-based firm developed an mRNA vaccine against Covid-19 last year - leading the global vaccination effort alongside Pfizer and BioNTech. But this came only after years of scepticism towards mRNA technology.
"What is very exciting is that not only did Moderna do the vaccine quickly, it was also incredibly effective," Dr Langer tells The Business Times (BT) over a video call from Florida. "It's not just promising; it's really a key step to hopefully ending the pandemic. It also opens the doors to a whole host of vaccination programmes."
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Features
Not just fun and games: How mobile games have become big business
Robot at your service: Singapore companies ride global wave to build next-gen robots
Nuclear power debate heats up in South-east Asia
Jurong Island: In search of a new miracle
Stay awhile: How long-stay serviced apartments may change the housing landscape
This was village life in Britain 3,000 years ago